Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - CASSAVA SCIENCES INC | Financial_Report.xls |
| 10-K - FORM 10-K - CASSAVA SCIENCES INC | d268570d10k.htm |
| EX-10.5 - LICENSE AGREEMENT - CASSAVA SCIENCES INC | d268570dex105.htm |
| EX-31.1 - CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO SECTION 302 - CASSAVA SCIENCES INC | d268570dex311.htm |
| EX-32.1 - CERTIFICATIONS OF THE CEO AND THE CFO PURSUANT TO 18 U.S.C. SECTION 1350 - CASSAVA SCIENCES INC | d268570dex321.htm |
| EX-31.2 - CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO SECTION 302 - CASSAVA SCIENCES INC | d268570dex312.htm |
| EX-10.4 - COLLABORATION AGREEMENT - CASSAVA SCIENCES INC | d268570dex104.htm |
| EX-10.20 - AMENDED LEASE AGREEMENT - CASSAVA SCIENCES INC | d268570dex1020.htm |
EXHIBIT 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statements (Form S-3 No. 333-164648, No. 333-127882, No. 333-115362, No. 333-108145, No. 333-106396) of Pain Therapeutics, Inc. and in the related Prospectus, and in the Registration Statements (Form S-8 No. 333-168390, No. 333-152676, No. 333-147336, No. 333-134364, No. 333-115361, No. 333-105138, No. 333-68118 and No. 333-41660) pertaining to the 2008 Equity Incentive Plan, the 1998 Stock Plan and 2000 Employee Stock Purchase Plan of Pain Therapeutics, Inc. of our reports dated February 9, 2012, with respect to the financial statements of Pain Therapeutics, Inc., and the effectiveness of internal control over financial reporting of Pain Therapeutics, Inc., included in this Annual Report (Form 10-K) for the year ended December 31, 2011.
/s/ Ernst & Young LLP
Austin, Texas
February 9, 2012